SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-064897
Filing Date
2019-11-18
Accepted
2019-11-18 08:02:57
Documents
10
Period of Report
2019-11-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-23017_18k.htm 8-K 35642
2 EX-1.1 a19-23017_1ex1d1.htm EX-1.1 350101
3 EX-4.1 a19-23017_1ex4d1.htm EX-4.1 81772
4 EX-5.1 a19-23017_1ex5d1.htm EX-5.1 15088
5 EX-99.1 a19-23017_1ex99d1.htm EX-99.1 10006
6 EX-99.2 a19-23017_1ex99d2.htm EX-99.2 10188
7 GRAPHIC g230171mm09i001.jpg GRAPHIC 4654
8 GRAPHIC g230171kai001.gif GRAPHIC 1512
9 GRAPHIC g230171kai002.gif GRAPHIC 332
10 GRAPHIC g230171kai003.gif GRAPHIC 328
  Complete submission text file 0001104659-19-064897.txt   513862
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 191226193
SIC: 2836 Biological Products, (No Diagnostic Substances)